1. Home
  2. MIST vs PAYS Comparison

MIST vs PAYS Comparison

Compare MIST & PAYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • PAYS
  • Stock Information
  • Founded
  • MIST 2003
  • PAYS 2001
  • Country
  • MIST Canada
  • PAYS United States
  • Employees
  • MIST N/A
  • PAYS N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • PAYS Business Services
  • Sector
  • MIST Health Care
  • PAYS Consumer Discretionary
  • Exchange
  • MIST Nasdaq
  • PAYS Nasdaq
  • Market Cap
  • MIST 145.3M
  • PAYS 125.2M
  • IPO Year
  • MIST N/A
  • PAYS 1998
  • Fundamental
  • Price
  • MIST $1.97
  • PAYS $5.73
  • Analyst Decision
  • MIST Strong Buy
  • PAYS Strong Buy
  • Analyst Count
  • MIST 3
  • PAYS 4
  • Target Price
  • MIST $6.33
  • PAYS $7.31
  • AVG Volume (30 Days)
  • MIST 1.2M
  • PAYS 728.1K
  • Earning Date
  • MIST 11-11-2025
  • PAYS 11-04-2025
  • Dividend Yield
  • MIST N/A
  • PAYS N/A
  • EPS Growth
  • MIST N/A
  • PAYS N/A
  • EPS
  • MIST N/A
  • PAYS 0.12
  • Revenue
  • MIST N/A
  • PAYS $68,539,381.00
  • Revenue This Year
  • MIST N/A
  • PAYS $35.12
  • Revenue Next Year
  • MIST N/A
  • PAYS $20.99
  • P/E Ratio
  • MIST N/A
  • PAYS $47.84
  • Revenue Growth
  • MIST N/A
  • PAYS 27.84
  • 52 Week Low
  • MIST $0.63
  • PAYS $1.80
  • 52 Week High
  • MIST $2.75
  • PAYS $8.88
  • Technical
  • Relative Strength Index (RSI)
  • MIST 67.34
  • PAYS 53.06
  • Support Level
  • MIST $1.75
  • PAYS $5.08
  • Resistance Level
  • MIST $1.83
  • PAYS $5.48
  • Average True Range (ATR)
  • MIST 0.09
  • PAYS 0.25
  • MACD
  • MIST 0.02
  • PAYS 0.10
  • Stochastic Oscillator
  • MIST 79.49
  • PAYS 82.29

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About PAYS Paysign Inc.

PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The Company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The company's revenues include fees generated from cardholder fees, interchange, card program management fees, transaction claims processing fees, and settlement income.

Share on Social Networks: